Displaying 1 - 50 of 3591 results
Released Company Title Industry Topic
14 Jan 2026
08:00 CET
CONSTELLATION OIL SERVICES HOLDING S.A. COSH Announces its Presentation for the Fearnley Securities Offshore Drilling and Service Seminar 60101015 Offshore Drilling and Other Services Non-regulatory press releases
14 Jan 2026
08:00 CET
- Confirmation du dépôt par Tasly d'une demande de mise sur le marché du vaccin développé par Pharnext - Legal
14 Jan 2026
07:31 CET
Mutares SE & CO KGaA Mutares has successfully completed the sale of LiBCycle, an inTime Group company, to Reverse Logistics Group by Reconomy 30202010 Asset Managers and Custodians Non-regulatory press releases
14 Jan 2026
07:30 CET
SCOR SE SCOR annonce des évolutions  au sein de son Comité exécutif 30302020 Reinsurance Journal / appointments
14 Jan 2026
07:30 CET
SCOR SE SCOR announces changes to its Group Executive Committee 30302020 Reinsurance Journal / appointments
14 Jan 2026
07:00 CET
VÅR ENERGI ASA Invitation to Vår Energi's Capital Markets Update 2026 60101015 Offshore Drilling and Other Services Non-regulatory press releases
14 Jan 2026
07:00 CET
MAGNORA Magnora reaches 10 GW project portfolio target adding high value assets 60102020 Renewable Energy Equipment Additional regulated information required to be disclosed under the laws of a Member State
14 Jan 2026
07:00 CET
NORCOD Norcod AS: Fixed Income Investor Meetings and Operational Update 45102010 Farming, Fishing, Ranching and Plantations Inside information
14 Jan 2026
07:00 CET
IPSEN New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS 20103015 Pharmaceuticals Products and services
14 Jan 2026
07:00 CET
ZAPTEC ASA Zaptec ASA: Buy-back of own shares to meet obligations arising from share incentive programs 50202040 Electronic Equipment: Other Acquisition or disposal of the issuer’s own shares
14 Jan 2026
07:00 CET
IPSEN De nouvelles données renforcent l’engagement d’Ipsen à proposer des solutions et à combler les lacunes de prise en charge dans les maladies neurologiques lors du congrès TOXINS 20103015 Pharmaceuticals Products and services
14 Jan 2026
07:00 CET
DSM FIRMENICH AG dsm-firmenich appoints Nikeisha van Sleeuwen as Chief Human Resources Officer 45102020 Food Products Journal / appointments
14 Jan 2026
02:54 CET
BARRAMUNDI GROUP LTD. Financial calendar 45102010 Farming, Fishing, Ranching and Plantations Additional regulated information required to be disclosed under the laws of a Member State
14 Jan 2026
00:52 CET
SOILTECH ASA Mandatory notification of trade and disclosure of large shareholding in connection with block sale 65102030 Water Additional regulated information required to be disclosed under the laws of a Member State
13 Jan 2026
22:51 CET
Diana Shipping Inc Diana Shipping Inc. Issues Statement Regarding Genco Shipping & Trading’s Response to Diana’s Acquisition Proposal - Non-regulatory press releases
13 Jan 2026
22:48 CET
SOILTECH ASA Completed block sale of existing shares in Soiltech ASA 65102030 Water Additional regulated information required to be disclosed under the laws of a Member State
13 Jan 2026
22:15 CET
NANOBIOTIX Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social 20103010 Biotechnology Other subject
13 Jan 2026
22:15 CET
NANOBIOTIX Voting Rights and Shares Capital of the Company 20103010 Biotechnology Other subject
13 Jan 2026
21:30 CET
Nordea Bank Abp Nordea Bank Abp: Repurchase of own shares on 13.01.2026 30101010 Banks Acquisition or disposal of the issuer’s own shares
13 Jan 2026
20:00 CET
BlueNord ASA BlueNord ASA: Disclosure of Shareholdings 60101010 Oil: Crude Producers Major shareholding notifications
13 Jan 2026
19:41 CET
M VEST WATER AS Mandatory Notification of Trade by Primary Insiders 50204000 Machinery: Industrial Mandatory notification of trade primary insiders
13 Jan 2026
19:30 CET
KALRAY DÉCLARATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS (ARTICLE L 233-8 II DU CODE DE COMMERCE) 10102010 Semiconductors Change in Capital
13 Jan 2026
19:30 CET
KALRAY BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE CONTRACTE AVEC LA SOCIETE DE BOURSE GILBERT DUPONT 10102010 Semiconductors Legal
13 Jan 2026
18:30 CET
SPINEWAY SPINEWAY : 2025 revenue of €12.4 million,  with an acceleration of sales in Q4 2025 (+34%) 20102010 Medical Equipment -
13 Jan 2026
18:30 CET
UMICORE Umicore - Transparency notifications by Bank of America Corporation 55201020 Specialty Chemicals New
13 Jan 2026
18:30 CET
UMICORE Umicore - Déclarations de transparence par Bank of America Corporation 55201020 Specialty Chemicals New
13 Jan 2026
18:30 CET
ERAMET Eramet confirme la solidité de ses performances environnementales avec une notation A- pour la transparence attribuée par le CDP 55102050 Nonferrous Metals Rating
13 Jan 2026
18:30 CET
UMICORE Umicore - Transparantieverklaringen van Bank of America Corporation 55201020 Specialty Chemicals New
13 Jan 2026
18:30 CET
ERAMET Eramet confirms the strength of its environmental performance with A- scores for transparency from CDP 55102050 Nonferrous Metals Rating
13 Jan 2026
18:30 CET
MEMSCAP REGPT MEMSCAP : BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE CONTRACTE AVEC LE CREDIT INDUSTRIEL ET COMMERCIAL 10102010 Semiconductors Legal
13 Jan 2026
18:30 CET
BE Semiconductor Industries N.V. BE Semiconductor Industries N.V. Announces Transactions Under Share Repurchase Program 10102010 Semiconductors Other subject
13 Jan 2026
18:30 CET
SPINEWAY SPINEWAY : Chiffre d’affaires annuel 2025 de 12,4 ME avec une accélération des ventes au T4 2025 (+34%) 20102010 Medical Equipment -
13 Jan 2026
18:29 CET
SHELL PLC Transaction in Own Shares 60101000 Integrated Oil and Gas Other subject
13 Jan 2026
18:27 CET
BENETEAU 260113 BENETEAU Déclaration du nombre d\'actions et de droits de vote au 31-12-2025 40203055 Recreational Vehicles and Boats Other subject
13 Jan 2026
18:19 CET
IPSEN U.S. FDA grants Ipsen’s IPN60340 (ICT01) Breakthrough Therapy Designation in first line unfit Acute Myeloid Leukemia 20103015 Pharmaceuticals Products and services
13 Jan 2026
18:19 CET
IPSEN La FDA américaine accorde la désignation « Breakthrough Therapy » à l’IPN60340 (ICT01) d’Ipsen dans la leucémie myéloïde aiguë de première ligne chez les patients inéligibles à une chimiothérapie intensive 20103015 Pharmaceuticals Products and services
13 Jan 2026
18:07 CET
IPSOS Ipsos: Half-year report on IPSOS’ liquidity contract - December 2025 40301020 Media Agencies Legal
13 Jan 2026
18:07 CET
IPSOS Ipsos : Bilan semestriel du contrat de liquidité IPSOS - Décembre 2025 40301020 Media Agencies Legal
13 Jan 2026
18:01 CET
ARAMIS GROUP Aramis Group - Mise à disposition des documents relatifs à l'Assemblée Générale 2026 40401030 Specialty Retailers General meeting / Board Meeting
13 Jan 2026
18:01 CET
ARAMIS GROUP Aramis Group - Availability of documents and information relating to the 2026 annual general meeting 40401030 Specialty Retailers General meeting / Board Meeting
13 Jan 2026
18:00 CET
OXURION Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC 20103010 Biotechnology Change in Capital
13 Jan 2026
18:00 CET
KALRAY MULTIPLICATION PAR 4 DU CHIFFRE D'AFFAIRES À PÉRIMÈTRE COMPARABLE ET CONFIRMATION D'UN EBITDA 2025 LARGEMENT POSITIF 10102010 Semiconductors Sales, Income
13 Jan 2026
18:00 CET
LANSON-BCC LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 décembre 2025 45101015 Distillers and Vintners Other subject
13 Jan 2026
18:00 CET
IMPLANET IMPLANET Reports Full-Year 2025 Revenue of €12.5 Million, Up Sharply by +33% 20102010 Medical Equipment Other subject
13 Jan 2026
18:00 CET
GROUPE TERA Approbation par l’Assemblée Générale Extraordinaire de Groupe TERA de la réduction de capital d’un montant maximal total de 500.000 euros de valeur nominale par voie d’offre publique de rachat d’actions 50202030 Electronic Equipment: Pollution Control General meeting / Board Meeting
13 Jan 2026
18:00 CET
IMPLANET IMPLANET annonce son chiffre d’affaires annuel 2025 à 12,5 M€, en forte progression de +33% 20102010 Medical Equipment Other subject
13 Jan 2026
18:00 CET
ELIS Elis: Disclosure of trading in own shares occured from January 6 to January 9, 2026 50205010 Industrial Suppliers Share history
13 Jan 2026
18:00 CET
GENFIT GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial 20103010 Biotechnology Other subject
13 Jan 2026
18:00 CET
KALRAY Fourfold increase in revenue on a comparable scope and confirmation of a strongly positive EBITDA in 2025 10102010 Semiconductors Sales, Income
13 Jan 2026
18:00 CET
GENFIT GENFIT : Bilan semestriel du contrat de liquidité contracté avec le Crédit Industriel et Commercial 20103010 Biotechnology Other subject